Major Investor Group, Including Director, Sells $162.5M in Secondary Offering

summarizeSummary

A group of selling stockholders, including entities managed by Director Jason Turowsky, completed the sale of 6.61 million shares for $162.5 million, significantly reducing their collective stake in Innovex International.

check_boxKey Events

• Secondary Offering Details

  Selling stockholders, including Amberjack Capital Fund II and Innovex Co-Invest Fund II, sold a total of 6,612,500 shares of common stock, including the full exercise of the underwriters' option.

• Significant Proceeds

  The sale generated approximately $162.5 million in proceeds for the selling stockholders, at a net price of $24.59125 per share.

• Reduced Stake

  The transaction represents a substantial reduction of approximately 22.5% of the selling stockholders' collective holdings, with their combined beneficial ownership now at 33.2% of outstanding shares.

• Lock-up Agreement

  The selling stockholders have entered into a 45-day lock-up agreement, restricting further sales without underwriter consent.

auto_awesomeAnalysis

This Schedule 13D/A provides the detailed breakdown of the secondary offering previously announced on February 25, 2026, and completed on February 27, 2026. The selling stockholders, primarily investment funds affiliated with Amberjack Capital and Intervale Capital, collectively sold 6,612,500 shares at a net price of $24.59125 per share, totaling approximately $162.5 million. This represents a substantial reduction of about 22.5% of their prior holdings and nearly 9% of the company's market capitalization. The sale by a major institutional group, which includes a director, signals a significant reduction in their exposure to the company. Investors should note the updated beneficial ownership percentages for these key stakeholders.